Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Fellows

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|August 31, 2015
Bayesian population modeling of drug dosing adherenceKelly Fellows, Colin J Stoneking, Murali Ramanathan
International Journal of MS Care|May 4, 2019
Marijuana Use by Patients with Multiple SclerosisSheila Gupta, Kelly Fellows, Bianca Weinstock-Guttman, et al.
The AAPS Journal|January 23, 2015
A hybrid Markov chain-von Mises density model for the drug-dosing interval and drug holiday distributionsKelly Fellows, Vivian Rodriguez-Cruz, Jenna Covelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2016
Interdependence of oxysterols with cholesterol profiles in multiple sclerosisShreya Mukhopadhyay, Kelly Fellows, Richard W Browne, et al.
Journal of Lipid Research|May 16, 2019
Oxysterols and apolipoproteins in multiple sclerosis: a 5 year follow-up studyKelly Fellows Maxwell, Sonia Bhattacharya, Mary Lou Bodziak, et al.
Plos One|June 19, 2019
Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot studyKelly Fellows Maxwell, Terry Wahls, Richard W Browne, et al.
Journal of Lipid Research|December 8, 2016
Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patientsTomas Uher, Kelly Fellows, Dana Horakova, et al.
Journal of Lipid Research|August 6, 2015
Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patientsKelly Fellows, Tomas Uher, Richard W Browne, et al.
The Journal of Rheumatology|January 15, 2025
Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 StudyPaul Emery, Roy Fleischmann, Robert Wong, et al.
Oncology Reports|February 4, 2010
Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growthAlissa Routhier, Michelle Astuccio, Deanna Lahey, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Pharmacokinetics and Pharmacodynamics|August 31, 2015
Bayesian population modeling of drug dosing adherenceKelly Fellows, Colin J Stoneking, Murali Ramanathan
International Journal of MS Care|May 4, 2019
Marijuana Use by Patients with Multiple SclerosisSheila Gupta, Kelly Fellows, Bianca Weinstock-Guttman, et al.
The AAPS Journal|January 23, 2015
A hybrid Markov chain-von Mises density model for the drug-dosing interval and drug holiday distributionsKelly Fellows, Vivian Rodriguez-Cruz, Jenna Covelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2016
Interdependence of oxysterols with cholesterol profiles in multiple sclerosisShreya Mukhopadhyay, Kelly Fellows, Richard W Browne, et al.
Journal of Lipid Research|May 16, 2019
Oxysterols and apolipoproteins in multiple sclerosis: a 5 year follow-up studyKelly Fellows Maxwell, Sonia Bhattacharya, Mary Lou Bodziak, et al.
Plos One|June 19, 2019
Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot studyKelly Fellows Maxwell, Terry Wahls, Richard W Browne, et al.
Journal of Lipid Research|December 8, 2016
Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patientsTomas Uher, Kelly Fellows, Dana Horakova, et al.
Journal of Lipid Research|August 6, 2015
Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patientsKelly Fellows, Tomas Uher, Richard W Browne, et al.
The Journal of Rheumatology|January 15, 2025
Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 StudyPaul Emery, Roy Fleischmann, Robert Wong, et al.
Oncology Reports|February 4, 2010
Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growthAlissa Routhier, Michelle Astuccio, Deanna Lahey, et al.
Pageof 1